Videos

Sabroxy® is a clinically studied nootropic supporting brain health

Sabroxy® is a clinically studied nootropic supporting brain health

Released by Sabinsa Corporation 10.30.23

In a 12-week randomized, double-blind, placebo-controlled trial, supplementation with 500 mg of Sabroxy® twice daily in older adults with self-reported memory complaints was associated with greater improvements in episodic memory and several computer-based cognitive tasks compared to the placebo.

LEARN MORE >>

More Videos by Sabinsa Corporation

Videos

Supporting Healthy Liver Functions, LivLonga® Is

...
Videos357016 12.01.20
Videos

Curcumin C3 Complex®: The Whole Picture & The Who

...
Videos357013 12.01.20
Videos

Highlighting 30 Years of Innovation

Sabinsa Road to 30
Videos294576 03.06.19
Videos

Investing in a Sustainable Botanical Supply Chain

Sabinsa Road to 30
Videos294083 03.06.19

More Content From Sabinsa Corporation

BioPerine Increases Ingredient Bioavailability

BioPerine® has been widely used to enhance the bioavailability of several dietary supplement ingredients and requires a very low dosage of 5mg per serving.

White Papers / Tech Papers Released on 06.20.2023
The Ingredients Driving Nutricosmetic Trends

Download to learn more about the latest nutricosmetics market trends and the specific ingredients driving them.

Sponsored Content Released on 04.11.2023
Dietary Supplements | Herbs & Botanicals | World Markets

Supplier Insights: Sabinsa Strengthens Supply Chains from the Ground Up

Shaheen Majeed, President Worldwide, Sabinsa, tells how the company is navigating uncertain times, the importance of IP/innovation, and plans for the future.

Sponsored Content Released on 11.10.2020
New Diabetic Research on Sabinsa’s Curcumin C3 Complex ® and BioPerine Combination Published

...

News Releases Released on 10.08.2018
Research on Curcumin’s Positive Effects on Microbiome Published

Sabinsa Supplied Curcumin C3 Complex® and BioPerine® to Researchers

News Releases Released on 09.17.2018
TUFTS - TOHOKU STUDY ON CURCUMIN + PIPERINE COMBINATION

VERIFIES SABINSA'S RESEARCH ON SYNERGISTIC PROPERTIES

News Releases Released on 04.03.2018
SABINSA’S CURCUMIN C3 COMPLEX® WITH BIOPERINE® SHOWS PROTECTIVE ROLE IN LIPID PROFILE MODIFICATION

IN TYPE 2 DIABETES IN PUBLISHED STUDY

News Releases Released on 06.19.2017
SABINSA’S CURCUMIN C3 COMPLEX® STUDIED FOR ANTIOXIDANT EFFECT IN DIABETES PATIENTS

RANDOMIZED, CONTROLLED STUDY PUBLISHED IN INFLAMMOPHARMACOLOGY

News Releases Released on 02.06.2017
UNIVERSITY RESEARCH COMPARING FIVE CURCUMIN BRANDS IDENTIFIES SABINSA’S CURCUMIN C3 COMPLEX

AS THE MOST ACTIVE FORM

News Releases Released on 11.16.2016
SABINSA’S CURCUMIN C3 COMPLEX® IN COMBINATION WITH OMEGA-‐3s FOUND TO HAVE SYNERGISTIC EFFECT

...

News Releases Released on 10.26.2016
APPROVAL FOR NEW HEALTH CLAIMS ON CURCUMIN C3 COMPLEX® AND CURCUMIN C3 REDUCT® IN CANADA

INCLUDES FIRST HEALTH CLAIM FOR A CURCUMIN METABOLITE

News Releases Released on 09.20.2016
SABINSA ANNOUNCES CURCUMIN TESTING PROGRAM TO ASSURE AUTHENTICITY IN CAMPAIGN

TO ELIMINATE ADULTERATION WITH SYNTHETICS

News Releases Released on 06.13.2016
METABOLIC SYNDROME STUDY ON SABINSA’S CURCUMIN C3 COMPLEX® HONORED

WITH UNIVERSITY RESEARCH OF THE YEAR AWARD

News Releases Released on 05.18.2016
CURRY POWDER TO CLINICAL SIGNIFICANCE

New Book Provides a Comprehensive Understanding of Curcumin & Studies on Curcumin C3 Complex®

News Releases Released on 12.10.2015
SABINSA’S CURCUMIN C3 COMPLEX ® TO BE SAFE ADJUNCT TO, AND ENHANCE EFFICACY OF, FOLFOX CHEMOTHERAPY

UK STUDY SHOWS

News Releases Released on 06.16.2015

Loading, Please Wait..

This content is sponsored by:

Visit the website

Sabinsa Corporation

Request Information